Tristel logo

Tristel

Stock
Stock
ISIN: GB00B07RVT99
Ticker: TSTL
GB00B07RVT99
TSTL

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Tristel has so far distributed $0.0763 in 2026. The next dividend will be paid on 18.12.2026


$0.135

CHART BY

Frequently asked questions

The market capitalization of Tristel is 207.92M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Tristel is 26.24. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Tristel's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.165. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Tristel's stock, with a consensus target price of 4.902. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Tristel reported a revenue of 49.54M.
Tristel's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 13.12M. EBITDA measures the company's overall financial performance.
Tristel has a free cash flow of 9.97M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Tristel employs approximately 267 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Tristel is 47.24M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
207.92M
EPS (TTM) 
$0.165
Free Float 
47.24M
P/E ratio (TTM) 
26.24
Revenue (TTM) 
49.54M
EBITDA (TTM) 
13.12M
Free Cashflow (TTM) 
9.97M

Pricing

1D span
$5.597$5.764
52W span
$4.583$6.08

Analyst Ratings

The price target is 4.902 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. It operates through the following segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Others. The company was founded by Paul C. Swinney in 1993 and is headquartered in Cambridgeshire, the United Kingdom.

Employees
267
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
GB00B07RVT99
Primary Ticker
TSTL

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation